PALO ALTO, Calif., Aug. 30, 2006 -- Agilent Technologies Inc. (NYSE: A) today announced it has obtained worldwide, non-exclusive patent licenses from Abbott Molecular Inc. for the manufacture, marketing and sale of oligonucleotide microarrays using a two-or-more color technology for gene expression and comparative genomic hybridization (CGH) applications.
